BetterLife Files Comprehensive Patent for BETR-001 and Other LSD Derivatives Pharmaceutical Investing
XEN® 63 Gel Implant available now for patients with primary open angle glaucoma where previous medical treatments have failed Pharmaceutical Investing
Merck's KEYTRUDA® Receives Four New Approvals in Japan, Including in High-Risk Early-Stage Triple-Negative Breast Cancer Pharmaceutical Investing
Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent Vaccine Booster in Children 5 Through 11 Years of Age Pharmaceutical Investing
Knight Therapeutics Inc. places No. 22 on The Globe and Mail's fourth-annual ranking of Canada's Top Growing Companies Pharmaceutical Investing
Gilead Joins First-of-its-Kind Public-Private Initiative to Improve Management of Viral Hepatitis in Vietnam and the Philippines Pharmaceutical Investing
The Forces of Beauty® Report from The DREAM Initiative® Reveals Demand for New Standards of Beauty and Imagery Pharmaceutical Investing
